In a nationwide observational study published this month in the Journal of the American Medical Association, cardiologists from the Smith Center for Outcomes Research at Beth Israel Deaconess Medical Center (BIDMC) have examined trends in the use and long-term safety of a device widely used to treat pulmonary embolism, or blood clots in the lungs.